Meeting to be held in New York on February 1 hosted by Mizuho.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ADMA:
- ADMA Biologics management to meet with Mizuho
- ADMA Biologics sees FY22 revenue $153-$154M, consensus $148.95M
- ADMA Biologics sees Q4 revenue $49-$50M, consensus $43.75M
- ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
- ADMA Biologics sees FY23 revenue $210M plus , consensus $197.45M